Summit Global Investments Novartis Ag Transaction History

Summit Global Investments

  • $1.7 Billion
  • Q2 2025

A detailed history of Summit Global Investments transactions in Novartis Ag stock. As of the latest transaction made, Summit Global Investments holds 5,866 shares of NVS stock, worth $699,872. This represents 0.04% of its overall portfolio holdings.

Number of Shares
5,866
Previous 13,121 55.29%
Holding current value
$699,872
Previous $1.46 Million 51.47%
% of portfolio
0.04%
Previous 0.11%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025
SELL
$101.96 - $121.01 $739,719 - $877,927
-7,255 Reduced 55.29%
5,866 $710,000
Q1 2025

Apr 07, 2025
SELL
$97.14 - $115.57 $2.24 Million - $2.66 Million
-23,033 Reduced 63.71%
13,121 $1.46 Million
Q4 2024

Feb 11, 2025
BUY
$96.78 - $117.18 $3.5 Million - $4.24 Million
36,154 New
36,154 $3.52 Million
Q4 2023

Feb 06, 2024
SELL
$92.27 - $101.54 $1.08 Million - $1.19 Million
-11,726 Reduced 32.94%
23,873 $2.41 Million
Q3 2023

Oct 13, 2023
BUY
$94.73 - $105.13 $375,130 - $416,314
3,960 Added 12.52%
35,599 $3.63 Million
Q2 2023

Jul 18, 2023
BUY
$92.52 - $104.91 $109,728 - $124,423
1,186 Added 3.89%
31,639 $3.19 Million
Q1 2023

May 04, 2023
BUY
$80.03 - $92.81 $14,645 - $16,984
183 Added 0.6%
30,453 $2.8 Million
Q4 2022

Jan 31, 2023
BUY
$75.55 - $92.52 $138,634 - $169,774
1,835 Added 6.45%
30,270 $2.75 Million
Q3 2022

Nov 14, 2022
BUY
$74.61 - $87.26 $864,431 - $1.01 Million
11,586 Added 68.76%
28,435 $2.16 Million
Q2 2022

Aug 23, 2022
SELL
$80.52 - $93.75 $59,262 - $69,000
-736 Reduced 4.19%
16,849 $1.42 Million
Q1 2022

Apr 29, 2022
SELL
$80.11 - $90.62 $3,524 - $3,987
-44 Reduced 0.25%
17,585 $1.54 Million
Q4 2021

Feb 14, 2022
BUY
$79.7 - $88.13 $4,463 - $4,935
56 Added 0.32%
17,629 $1.54 Million
Q3 2021

Nov 08, 2021
BUY
$81.78 - $95.14 $385,265 - $448,204
4,711 Added 36.63%
17,573 $1.44 Million
Q2 2021

Jan 28, 2022
SELL
$85.24 - $94.15 $55,491 - $61,291
-651 Reduced 4.82%
12,862 $1.17 Million
Q1 2021

Jan 27, 2022
BUY
$83.5 - $98.47 $111,138 - $131,063
1,331 Added 10.93%
13,513 $1.16 Million
Q4 2020

Feb 11, 2021
BUY
$78.07 - $94.43 $190,490 - $230,409
2,440 Added 25.05%
12,182 $1.15 Million
Q3 2020

Nov 16, 2020
BUY
$82.14 - $91.0 $63,001 - $69,797
767 Added 8.55%
9,742 $847,000
Q2 2020

Aug 11, 2020
BUY
$80.93 - $91.1 $140,170 - $157,785
1,732 Added 23.91%
8,975 $784,000
Q1 2020

May 14, 2020
SELL
$70.67 - $99.01 $131,234 - $183,861
-1,857 Reduced 20.41%
7,243 $597,000
Q4 2019

Feb 13, 2020
BUY
$84.35 - $95.37 $108,811 - $123,027
1,290 Added 16.52%
9,100 $862,000
Q3 2019

Nov 08, 2019
SELL
$85.54 - $94.26 $63,299 - $69,752
-740 Reduced 8.65%
7,810 $679,000
Q2 2019

Aug 16, 2019
BUY
$75.4 - $92.8 $644,670 - $793,440
8,550 New
8,550 $781,000

Others Institutions Holding NVS

# of Institutions
1,557
Shares Held
136M
Call Options Held
1.73M
Put Options Held
1.69M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $257B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Summit Global Investments Portfolio

Follow Summit Global Investments and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Global Investments, based on Form 13F filings with the SEC.

News

Stay updated on Summit Global Investments with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email